Access to treatment and educational inequalities in cancer survival by Fiva, Jon H. et al.
Discussion 
Papers
Statistics Norway
Research department
No. 735 •
February 2013
Jon H. Fiva, Torbjørn Hægeland, 
Marte Rønning and Astri Syse
Access to treatment and educational 
inequalities in cancer survival
Discussion Papers No. 735, February 2013 
Statistics Norway, Research Department 
Jon H. Fiva, Torbjørn Hægeland,  
Marte Rønning and Astri Syse 
Access to treatment and educational inequalities in 
cancer survival 
Abstract: 
The public health care systems in the Nordic countries provide high quality care almost free of 
charge to all citizens. However, social inequalities in health persist. Previous research has, for 
example, documented substantial educational inequalities in cancer survival. We investigate to what 
extent this may be driven by differential access to and utilization of high quality treatment options. 
Quasi-experimental evidence based on the establishment of regional cancer wards indicates that i) 
highly educated individuals utilized centralized specialized treatment to a greater extent than less 
educated patients and ii) the use of such treatment improved these patients' survival. 
Keywords: Education, Health, Inequality 
JEL classification: I10, I20 
Acknowledgements: We are grateful to Sara Cools, Morten Tandberg Eriksen, Øystein Kravdal, 
Edwin Leuven, Adriana Lleras-Muney, Imran Rasul, Kjell Gunnar Salvanes, Marcello Sartarelli and 
Steinar Tretli, and seminar participants at the Cancer Registry of Norway, VATT Helsinki, University 
of Oslo, the 2012 NTNU Workshop in Educational Governance, the 2013 North American Winter 
Meeting of the Econometric Society, for helpful comments and suggestions. Some of the data in this 
article are from the Cancer Registry of Norway. The Cancer Registry of Norway is not responsible for 
the analysis or interpretation of the data presented. This paper is part of the research activities at the 
center of Equality, Social Organization, and Performance (ESOP) at the Department of Economics at 
the University of Oslo. ESOP is supported by the Research Council of Norway. 
Address: Jon H. Fiva, Department of Economics, BI Norwegian Business School.  
E-mail: jon.h.fiva@bi.no 
Torbjørn Hægeland, Statistics Norway, Research Department. E-mail: thd@ssb.no 
Marte Rønning, Statistics Norway, Research Department. E-mail: mro@ssb.no 
Astri Syse, Norwegian Social Research. E-mail: astri.syse@nova.no 
Discussion Papers comprise research papers intended for international journals or books. A preprint of a 
Discussion Paper may be longer and more elaborate than a standard journal article, as it 
may include intermediate calculations and background material etc. 
 
 
 
 
© Statistics Norway 
Abstracts with downloadable Discussion Papers 
in PDF are available on the Internet: 
http://www.ssb.no 
http://ideas.repec.org/s/ssb/dispap.html 
 
For printed Discussion Papers contact: 
Statistics Norway 
Telephone: +47 62 88 55 00 
E-mail: Salg-abonnement@ssb.no 
 
ISSN 0809-733X 
Print: Statistics Norway 
3 
Sammendrag 
Det offentlige helsevesenet i nordiske land sørger for tilnærmet gratis helsetjenester av høy kvalitet til 
alle innbyggerne. Likevel er det ulikheter i helse og helseutfall på tvers av sosioøkonomiske grupper. 
Tidligere forskning har for eksempel dokumentert betydelige forskjeller i kreftoverlevelse mellom 
utdanningsgrupper. Vi undersøker i hvilken grad slike forskjeller kan være drevet av forskjeller i 
tilgang til og bruk av spesialisert behandling. Våre kvasi-eksperimentelle resultater basert på 
etablering av regionale kreftavdelinger indikerer at i) høyt utdannede pasienter brukte spesialisert og 
sentralisert behandling i større grad enn de med lav utdanning, og ii) slik behandling bedret sjansen for 
overlevelse. 
1 Introduction
Educational inequalities in mortality rates have been documented across a wide
range of countries. Diﬀerences in lifestyle and health behaviors are major factors
driving the positive association between education and health, but the quality
of treatment of various diseases could also play a role. Treatment quality is
expected to depend on income when health services must be bought in the
open market, such as in the United States. This is less obvious in egalitarian
welfare states such as the Nordic countries, where public health care systems
aim to oﬀer equal access to high quality health care, regardless of socioeconomic
status and geographic location. This is particularly true for cancer diagnosis,
treatment, and care, where private options are virtually nonexistent. Against
this background, it is surprising that educational inequalities in cancer mortality
are of a similar magnitude in the United States and in the Nordic countries (cp.
Kinsey et al. 2008; Elstad et al. 2012).
A diﬀerence in economic resources is not the only possible mechanism behind
the relationship between education and health. Highly educated individuals
may utilize better treatment options within the health care system for various
reasons. People with higher education could, for example, have a better under-
standing of the relationship between health inputs (behavior and treatment) and
health outcomes (Kenkel, 1991). Glied and Lleras-Muney (2008) ﬁnd that bet-
ter educated individuals have a greater survival advantage from diseases where
there has been more health-related technological progress. This indicates that
people with higher education are the ﬁrst to take advantage of technological
advances that improve health.
A related hypothesis is that more highly educated people may be better at
ﬁnding their way through the health bureaucracy, claiming their rights, acquir-
ing relevant information, and communicating their symptoms. Several studies
show that patient-provider communication varies with patients' socioeconomic
status, with the level of education being of particular importance (e.g., Smith
et al. 2009; Marks et al. 2010, Grytten et al. 2011). Bago d'Uva and Jones
(2009) document that more highly educated individuals use specialist care more
frequently in many European countries, irrespective of actual needs.
In this paper, we investigate how access to and utilization of highly spe-
cialized treatment aﬀects survival after cancer, and how this is related to edu-
cational attainment. We use individual level data covering all primary cancer
diagnoses in Norway in the period 1980-2000. During this period, patients were
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allocated to local hospitals based on their residential addresses, and they were
only transferred to other hospitals if specialized treatment was deemed neces-
sary. Typically, patients would be transferred to the national hospitals located
in Oslo for specialized treatment (Kravdal, 2006).1 However, patient-doctor in-
teractions could also play a role since referral practices and treatment protocols
are not fully codiﬁed. In our analysis, being treated in the health region where
the national hospitals are located is a proxy for specialized treatment. To ana-
lyze how specialized treatment aﬀects survival probabilities, we make use of the
fact that regional cancer wards opened at diﬀerent points in time in cities with
universities outside the Oslo area.
Several studies document that there are fewer complications and improved
survival chances at more specialized centers (for example, Black and Johnston,
1990; Kelly and Hellinger, 1986). Hospital volume and surgeon competency
have been shown to particularly important (Porter et al., 1998, Wibe et al.,
2005). In our context, the care provided in the newly opened regional cancer
wards could therefore have been of lower quality than the care provided at the
well-established national hospitals, especially in the period shortly after their
establishment.The opening of the new wards can therefore be interpreted as
representing a decrease in access to specialized treatment for patients residing
in these regions. The opening of the regional wards and the subsequent build-
up of local knowledge and expertise meant that transferring patient groups
with common cancer forms between health regions was no longer warranted.
The decentralization process was therefore accompanied by stricter regulations
concerning which cases should be treated centrally versus locally. The opening
of regional wards therefore meant that there was less scope for diﬀerences in
access to and the use of specialized treatment at the national hospitals that
were not directly related to disease characteristics.
We use the time variation in the establishment of the regional cancer wards
as a quasi-experiment providing exogenous variation in access to specialized
treatment. Within a diﬀerences-in-diﬀerences framework, we thus exploit the
sudden fall in the transfer rate to the national hospitals in Oslo in two out of
three health regions (Central and Northern) to investigate how specialized treat-
ment aﬀects survival. The Western health region serves as the control group,
as its transfer rate to Oslo was stable during the period under investigation.
By applying a diﬀerences-in-diﬀerences-in-diﬀerences set-up, we also investigate
1This is largely due to the availability of surgical equipment and expertise, but also because
of the absence of comprehensive oncology teams in regions outside the Oslo area.
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the extent to which educational inequalities in cancer survival were aﬀected by
the opening of the regional cancer wards.
Our estimates yield two important insights. Firstly, after controlling for the
general time trend, survival rates declined in regions where cancer wards were
opened. The eﬀect was particularly pronounced for patients living close to a
newly established ward. Secondly, we document that the survival probability
fell most strongly for patients with a university level education. This entails a
reduction in educational inequalities in cancer survival. Prior to the decentral-
ization, patients with a university level education were much more likely to be
transferred to the national hospitals than patients without such education. A
plausible explanation for the drop in the transfer probability diﬀerentials is that
stricter transfer regulations made it more diﬃcult to use a possible information
or competency advantage to gain access to specialized treatment. Our results
thereby suggest that educational inequalities may depend upon health sector
organization.
Our paper is related to the rapidly growing literature on the causal eﬀects
of education on health, typically using compulsory schooling laws as a source of
identiﬁcation. The results of these studies are, however, mixed. Lleras-Muney
(2005), who was the ﬁrst to make use of such laws in the US context, ﬁnds a
strong reduction in mortality for each year of additional schooling.2 This is in
contrast to, for example, Clark and Royer (2012) and Meghir et al. (2012), who
fail to ﬁnd beneﬁcial eﬀects on health of compulsory schooling reforms in the
United Kingdom and Sweden.3 Our paper ﬁts with this literature by empiri-
cally substantiating a plausible channel for the creation of health disparities by
education.
2 Institutional Setting
The public health care system in Norway oﬀers treatment, including highly spe-
cialized cancer care, universally and almost free of charge (Molven and Ferkis,
2011). In the period 1980-2000, hospitals were ﬁnanced by the central gov-
ernment, but were owned and run by the regional authorities. Patients could
be treated either at local hospitals, typically covering one or more municipality
(n=431), at regional hospitals covering all municipalitys within a county (n=19),
2Later research has shown that this result is sensitive to the inclusion of state speciﬁc
trends (Mazumder, 2008).
3Cutler and Lleras-Muney (2012) and Mazumder (2012) review this literature.
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or at one of the two highly specialized hospitals with national responsibilities.4
As shown in Figure 1, the counties are organized in four health regions
(South-Eastern; Western; Central; Northern).5 The national hospitals, Rikshos-
pitalet University Hospital and the Norwegian Radium Hospital, are located in
Oslo, the capital of Norway, in the South-Eastern health region.6 We refer to
this region as the Oslo region.
In the period covered by our study, patients were allocated to local hospi-
tals based on their residential addresses.7 The decision to either treat patients
at local hospitals or transfer them to more specialized care depended on an
overall assessment of patients' age, cancer form and spread, likely outcomes,
and the availability of specialized treatment, including surgical, radiation and
chemotherapeutic options within the catchment area. Since referral practices
and treatment protocols were not fully codiﬁed, patient-doctor interaction is
also likely to have played a role.
As radiation treatment requires a series of treatments at designated hos-
pitals, it is the treatment form most strongly related to place of residence.
Closeness to a radiation unit strongly predicts its use (NOU 1997: 20). Until
the early 1970's, Oslo was the only health region that oﬀered adjuvant radia-
tion and chemotherapy.8 Hence, prior to the establishment of regional cancer
4Hospital ownership was transferred to the central government in 2002. In the 1970's,
hospitals received 50-75% of their operating expenditure as per diem reimbursements from
the state. The remainder was provided by the regional government from tax revenues with
the overall tax rate set at the national level. This highly centralized ﬁnancing system implicitly
rewarded hospitals with inherently high costs. To provide incentives for cost-eﬃciency, state
reimbursements were replaced in 1980 by a block grant system based on demographic criteria
(Carlsen, 1994). This reform was partly reversed in 1997, when activity based ﬁnancing was
introduced (Hagen and Kaarbøe, 2006).
5Five health regions existed up until 2002, after which two of them (Southern and Eastern)
merged. Our data follow the most recent health region structure.
6Today, they both belong to the Oslo University Hospital, along with other teaching hos-
pitals in the Oslo area.
7Our register data allow us to follow patients up until the end of 2008. This means that we
can study ﬁve-year survival rates for patients diagnosed with cancer in 2003 at the latest. We
have therefore chosen to exclude data for the period after the system of free hospital choice
within care levels was introduced in 2001. Our main results are not altered in any substantial
way if we include data through 2003.
8Surgical treatment, which has been available in Norway for more than 150 years, is the pri-
mary treatment for most cancer forms. Patients may also be treated with radiation (available
in Oslo since the 1950's) and/or chemotherapy (available since the early 1970s). According
to a Norwegian Government White Paper from 1997 (NOU 1997: 20, Omsorg og kunnskap!)
around 85% of cured Norwegian patients received surgery. During the period we study, ra-
diation therapy was involved in around 40% of the cases, whereas chemotherapeutic drugs
were estimated to have been involved in around 14% of treatments. The use of radiation was
limited until the late 1950's, but it gradually became more prevalent in the 1960's and 1970's.
Today, multimodal treatment regimens, i.e., various combinations of surgery, radiation, and
chemotherapy, predominate.
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Figure 1: Health Regions in Norway
West South-East
(Oslo)
Central
North
Rikshospitalet Univ. Hospital
and
Norwegian Radium Hospital
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wards in 1972, 1985, and 1987 for the Western, Northern, and Central regions,
respectively, patients were required to travel to the Oslo region to obtain this
type of treatment.
Prior to the opening of the regional oncological wards, the standard practice
at local hospitals was to consult oncological surgeons at the Radium Hospital in
Oslo prior to diagnosis and treatment, as well as during the course of treatment.
The Radium Hospital was the primary oncological hospital in Norway prior to
the 1980's, and referrals were made almost exclusively to this hospital.9
Referral patterns changed after the opening of the regional oncological wards,
so that patients were primarily sent to these regional wards for diagnosis and,
when necessary, treatment. In cases where further treatment was deemed neces-
sary, referrals to the Radium Hospital were primarily initiated by these regional
oncological wards, typically after telephone consultations between the two. Af-
ter the opening of the regional wards, transfers of large patient groups with
common cancer forms between regions was thus no longer warranted.10 By
the year 2000, comprehensive oncological teams comprising pathologists, radi-
ologists, oncologists, oncological surgeons, and other relevant health personnel
were present in all four health regions, and the regional hospitals in Bergen,
Tromsø and Trondheim were all incorporated in university settings.11
3 Data and Descriptive Statistics
Our analyses are based on individual level data from the Cancer Registry of
Norway matched with data on patients' level of education from administrative
registers from Statistics Norway. We distinguish between patients who have
9Searches in newspaper archives indicate that doctors from the Northern health region
received training in Oslo prior to the opening of the regional wards.
10Due to a lack of information about patients' exact residential addresses and the treating
hospitals within the regions, we are unable to investigate transfers within health regions.
11National guidelines for the diagnosis and treatment of the most prevalent cancer forms
were introduced from the mid-1990's, and cancer care was gradually standardized and central-
ized within the respective health regions in order to ensure optimal treatment and outcomes
(see e.g., Wibe et al. (2003) and Kalager et al. (2009) for descriptions of surgical and onco-
logical management of colorectal and breast cancer, respectively). In practice, this resulted
in a substantial decline in the number of hospitals performing cancer surgery, from around 65
in the late 1980's to around 20 in the late 1990's and in the emergence of multidisciplinary
oncology teams providing high-quality care at designated regional hospitals. Throughout the
period assessed, guidelines have been in place that require specialized treatment at national
hospitals (also after the establishment of the regional cancer wards) for pediatric cancer pa-
tients and young adult patients with fertility issues, as well as for patients with certain rare
cancer forms. This is in order to ensure that patients are handled by experienced medical
personnel in units that are familiar with relevant diagnostic and treatment protocols.
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Figure 2: Proportion of patients transferred to Oslo by health region and county
with university hospital
university level education (higher education)12 and patients without a university
level education (lower education).
The Cancer Registry contains detailed information about the date of diag-
nosis, the patient's age at diagnosis, and gender, tumor location (International
Classiﬁcation of Diseases, 10th revision (ICD-10)), stage at diagnosis (local,
regional, distant or unknown), residential municipality on the date of diagno-
sis (ﬁrst course of treatment), and about which health region the patient was
treated and/or examined in.
We limit our sample to individuals residing outside the Oslo region who were
between 30 and 75 years old when ﬁrst diagnosed with cancer.13 This results in
99,988 individuals in total, 10% of whom have a higher education.
A descriptive overview of the variables used in this paper is provided in
Appendix Table 5. The main outcome variable in our study is a dummy variable
equal to one if the patient is alive ﬁve years after diagnosis, and zero otherwise
(survival). A patient is assumed to receive high quality treatment if she/he
has been treated and/or examined in the Oslo region, where the two national
hospitals are located (referred to as transfer in the following).
12This includes education at university colleges.
13We restrict the analyses to individuals aged 30 years or older, because, at this age, most
individuals have completed their education and because cancer treatment for children and
young adults is largely centralized in Norway. We also exclude cancer patients who were older
than 75 years at diagnosis. Transfer and survival rates are low for this age group (1.38% and
23.38%, respectively), and comorbid conditions must be taken into account when considering
treatment. About 10% of all patients are diagnosed with more than one form of cancer. We
restrict the analyses to patients diagnosed with their ﬁrst cancer only. The median age at
diagnosis was 64.
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3.1 Transfer and survival
The left panel of Figure 2 documents the extent of transfers from the Western,
Central and Northern regions to the Oslo region. The extent of transfers has
decreased over time or all health regions. These changes are mostly due to
university hospitals outside Oslo having become better equipped over time in
terms of personnel, laboratories, and surgical and radiological equipment. The
opening of a cancer ward in Trondheim in 1987 resulted in a drop in the transfer
probability from 0.25 in 1986 to 0.11 in 1988. Similarly, the opening of a cancer
ward in Tromsø in 1985 resulted in a more gradual drop in the transfer proba-
bility from 0.37 in 1984 to 0.13 in 1989.14 For patients from the Western health
region, there was no substantial change in the transfer probability during the
1980's. The university hospital in the Western health region opened a cancer
ward already in 1972, which was fully operational by 1976.
Because Norway is a outstretched country, travelling distances within health
regions are great for many patients. For example, the Northern region covers
an area that would take about 20 hours to drive across (about 1,000 miles).15
The traveling distance to the nearest cancer ward may be long even after the
establishment of regional cancer wards. Traveling by plane is therefore an option
that is likely to be utilized by many patients, and that could also aﬀect the
health authorities' decision whether or not to transfer patients to Oslo. The
right panel of Figure 2 shows transfer rates for the counties where the university
hospitals are located. The decline in transfer rates is more pronounced for this
sub-sample. This is reasonable, since traveling time was reduced most for this
group of patients.
The ﬁve-year all-cause survival rate following a cancer diagnosis increased
from 0.43 in 1980 to 0.59 in 2000. As documented in Figure 3, there are some
diﬀerences between the health regions.16 In the early 1980's, survival rates were
very similar across all health regions, but the survival rate in Northern Norway
started to lag behind from about 1985. This coincided with the opening of the
cancer ward in Tromsø. The same pattern is also evident when the analysis is
14There a slight reduction in the transfer rate in the Central region prior to the opening
of a regional cancer ward. This reﬂects the fact that a small proportion of patients received
treatment in the newly opened cancer ward in the Northern region in 1985-1986.
15According to Google Maps, the Central region, the Western region and the Oslo region
each cover an area that would take about 9 to 10 hours to drive across (about 350 to 450
miles).
16Although individuals living in the Oslo region are not included in the analyses, we in-
clude the ﬁve-year survival rate for the Oslo region in Appendix Figure 8 for comparison and
completeness purposes.
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Figure 3: Five-year survival rates by year of diagnosis and health region
limited to patients residing in the counties where the university hospitals are
located (right panel of Figure 3).
As cancer is a serious disease, local physicians are generally quick to refer
patients with a suspected malignancy to an appropriate diagnostic work-up.
Such work-ups have been available at hospitals at all levels (i.e., local, regional,
and national) throughout the period we have studied. It has been possible
for local hospitals without their own laboratories to send specimens to either
private laboratories or laboratories at larger hospitals for the necessary analyses.
It is therefore not surprising that the opening of regional cancer wards does not
appear to have had a signiﬁcant impact on the number of patients diagnosed
with cancer. Figure 4 plots the development in the number of patients across
health regions.17 Stage at diagnosis also shows a similar development in the
Western, Central and Northern regions (see Figure 5). The pronounced change
in the number of cancer cases with unknown stage is the result of changes in
the coding practice at the Cancer Registry of Norway in the mid-1980's. 18
3.2 Educational inequalities in transfer and survival
Treatment in Oslo and cancer survival are both strongly related to the patients'
level of education. In columns (1) and (2) of Table 1, we present results from
regressing patients' level of education on transfer and survival using a linear
probability model for the whole study period. The results for transfer are re-
17Neither did the opening of regional cancer wards signiﬁcantly impact on the number of
cancer patients in the Oslo region (see Appendix Figure 9).
18Unless it was positively conﬁrmed that there was no distant spread, cases were from
this point onwards coded as having an unknown spread whereas such cases were previously
assigned a stage based on their reported degree of spread, locally or regionally. Before the
mid-1980's it was thus assumed that, if no distant spread was noted, there was none.
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ported in the upper panel of the table, whereas the results for survival are
reported in the lower panel.19 The probability of being transferred to the Oslo
region is 1.7 percentage points higher for patients with a higher education rel-
ative to those with a lower education. The eﬀect is statistically signiﬁcant at
the one percent level. Individual with a higher education are also more likely
to survive cancer. This result has previously been documented for Norway and
other countries (see, for example, Kravdal 2000, Du et al. 2006, Lang et al.
2009, Fiva, Hægeland and Rønning, 2010, Kravdal and Syse, 2011).
Cancer covers many diagnoses that diﬀer greatly with respect to severity
and treatability. If diagnosis is correlated with education, this may bias our
estimates. When controlling for disease characteristics such as cancer type and
stage at diagnosis (column (2)), the model improves considerably (the R-squared
roughly doubles), and the association between level of education and transfer
probability increases to 2.6 percentage points. This indicates that patients with
a university level education tend to be less in need of specialized care at national
hospitals. This is consistent with previous studies that have documented that
people with higher education are more likely to be diagnosed at an earlier stage
(Clegg et al. 2009). The eﬀect of education on survival, on the other hand,
decreases when disease controls are added. Part of the (unadjusted) educational
inequality in cancer survival is therefore due to diﬀerences in disease severity.
We also relate the probability of transfer and survival, respectively, to pa-
tients' type of education. The left panel of Figure 6 shows that being educated
as a doctor increases the probability of being transferred to Oslo by about ﬁve
percentage points relative to those educated as teachers (the reference group).
This is an increase of around 40% in the transfer probability relative to the base-
line transfer rate (13%). Doctors also have about a ﬁve percentage points higher
probability of surviving cancer. Lawyers and other health care professionals also
have a statistically signiﬁcant higher probability of receiving treatment in Oslo,
but this does not manifest itself in a higher survival probability for these groups.
Estimates reported in Figure 6 are from speciﬁcations that include a full
battery of patient and disease characteristics. Together with the diﬀerences with
respect to level of education, these ﬁndings indicate that, even in an egalitarian
welfare state, access to treatment appears to depend on socioeconomic status.
More highly educated and better informed patients appear to receive better
treatment than others.
19Since all our control variables are discrete, we estimate linear probability models (as
recommended by Angrist, 2001).
14
Figure 6: Diﬀerences across educational disciplines in patients with higher edu-
cation
Medicine
Law
Health Sciences
Hum. and Soc. Sciences
Business
Natural Sciences
−.1 −.05 0 .05 .1
Transfer Probability
Medicine
Law
Health Sciences
Hum. and Soc. Sciences
Business
Natural Sciences
−.1 −.05 0 .05 .1
Survival Probability
Note: Estimates and corresponding 95% conﬁdence intervals from linear prob-
ability models are reported. The sample is limited to patients with a university
level education (n=10,071). Patients educated as teachers comprise the refer-
ence group. Time ﬁxed eﬀects, county ﬁxed eﬀects and a full battery of patient
and disease characteristics are included. The mean for survival is 0.65. The
mean for transfer is 0.13.
3.3 Regional cancer wards and educational inequalities in
transfer and survival
In columns (3)-(8) of Table 1, we show separate results for educational inequal-
ities for each health region.20 We examine the periods before and after the
opening of the regional cancer wards separately (henceforth the pre and post
periods).21
During the pre-reform period in the Central region, the probability of being
transferred was 4.8 percentage points higher for a patient with a higher edu-
cation (relative to a patient with a lower education). The diﬀerence fell to 1.5
percentage points during the post-reform period, 1987-2000 (see upper panel
columns (3) and (4)). A similar pattern was also found for survival (see lower
panel columns (3) and (4)). Before the opening of a regional cancer ward, the
diﬀerence in survival probability between patients with higher and lower ed-
ucation was 7.2 percentage points, compared to 3.4 after the opening. This
diﬀerence is substantial. To put this into perspective, overall survival probabil-
ity increased from 0.43 to 0.59 from 1980 to 2000, corresponding to an annual
increase of 0.8 percentage points. If all the educational inequalities were due to
20Unfortunately, we have too few observations in the pre-reform period to conduct a mean-
ingful statistical analysis based on patients' type of education.
21TheWestern region is assigned the same pre-reform and post-reform periods as the Central
region.
15
T
a
b
le
1
:
T
h
e
re
la
ti
o
n
sh
ip
b
et
w
ee
n
ed
u
ca
ti
o
n
a
n
d
tr
a
n
sf
er
,
a
n
d
ed
u
ca
ti
o
n
a
n
d
ﬁ
ve
-y
ea
r
su
rv
iv
a
l,
a
t
re
g
io
n
a
l
le
ve
ls
C
en
tr
a
l/
N
o
rt
h
/
W
es
t
C
en
tr
a
l
N
o
rt
h
W
es
t
P
re
P
o
st
P
re
P
o
st
P
re
P
o
st
1
9
8
0
-2
0
0
0
1
9
8
0
-8
6
1
9
8
7
-2
0
0
0
1
9
8
0
-8
4
1
9
8
5
-2
0
0
0
1
9
8
0
-8
6
1
9
8
7
-2
0
0
0
(1
)
(2
)
(3
)
(4
)
(5
)
(6
)
(7
)
(8
)
T
r
a
n
s
f
e
r
H
ig
h
er
ed
u
ca
ti
o
n
0
.0
1
7
0
.0
2
6
0
.0
4
8
0
.0
1
5
0
.0
2
5
0
.0
4
2
0
.0
4
8
0
.0
2
3
(0
.0
0
4
)*
*
*
(0
.0
0
4
)*
*
*
(0
.0
1
6
)*
*
*
(0
.0
0
5
)*
*
*
(0
.0
4
0
)
(0
.0
0
8
)*
*
*
(0
.0
1
0
)*
*
*
(0
.0
0
6
)*
*
*
S
u
r
v
i
v
a
l
H
ig
h
er
ed
u
ca
ti
o
n
0
.0
8
4
0
.0
3
8
0
.0
7
2
0
.0
3
4
0
.0
3
6
0
.0
4
3
0
.0
2
3
0
.0
3
7
(0
.0
0
5
)*
*
*
(0
.0
0
4
)*
*
*
(0
.0
1
6
)*
*
*
(0
.0
0
6
)*
*
*
(0
.0
2
5
)
(0
.0
1
0
)*
*
*
(0
.0
1
2
)*
(0
.0
0
7
)*
*
*
C
o
n
tr
o
ll
in
g
fo
r
d
is
ea
se
ch
a
r
N
o
Y
es
Y
es
Y
es
Y
es
Y
es
Y
es
Y
es
N
o
o
f
o
b
s
9
9
,9
8
8
9
9
,9
8
8
9
9
2
0
2
2
,5
6
5
5
1
2
4
1
7
,9
5
1
1
3
,1
2
6
3
1
,3
0
2
N
o
te
:
T
h
e
d
ep
en
d
en
t
va
ri
a
b
le
in
th
e
u
p
p
er
p
a
n
el
is
a
d
u
m
m
y
va
ri
a
b
le
th
a
t
eq
u
a
ls
o
n
e
if
th
e
p
a
ti
en
t
w
a
s
ex
a
m
in
ed
a
n
d
/
o
r
re
ce
iv
ed
tr
ea
tm
en
t
in
th
e
O
sl
o
re
g
io
n
.
T
h
e
d
ep
en
d
en
t
va
ri
a
b
le
in
th
e
lo
w
er
p
a
n
el
is
a
d
u
m
m
y
va
ri
a
b
le
th
a
t
eq
u
a
ls
o
n
e
if
th
e
p
a
ti
en
t
is
a
li
ve
ﬁ
v
e
ye
a
rs
a
ft
er
ca
n
ce
r
d
ia
g
n
o
si
s.
E
a
ch
ce
ll
re
p
re
se
n
ts
co
eﬃ
ci
en
ts
fr
o
m
O
L
S
re
g
re
ss
io
n
s.
S
ta
n
d
a
rd
er
ro
rs
w
it
h
in
b
ra
ck
et
s
a
re
h
et
er
os
ce
d
a
st
ic
ro
b
u
st
a
n
d
co
rr
ec
te
d
fo
r
cl
u
st
er
in
g
a
t
th
e
(r
es
id
en
ti
a
l)
m
u
n
ic
ip
a
li
ty
le
ve
l
a
t
th
e
ti
m
e
o
f
d
ia
g
n
o
si
s.
A
co
n
st
a
n
t
te
rm
a
n
d
d
u
m
m
y
va
ri
a
b
le
s
fo
r
a
g
e
a
t
d
ia
g
n
o
si
s,
g
en
d
er
,
ye
a
r
o
f
d
ia
g
n
o
si
s
a
n
d
co
u
n
ty
o
f
re
si
d
en
ce
a
re
in
cl
u
d
ed
in
a
ll
sp
ec
iﬁ
ca
ti
o
n
s.
*
/
*
*
/
*
*
*
d
en
o
te
st
a
ti
st
ic
a
l
si
g
n
iﬁ
ca
n
ce
a
t
th
e
1
0
/
5
/
1
p
er
ce
n
t
le
ve
ls
,
re
sp
ec
ti
v
el
y.
16
T
a
b
le
2
:
T
h
e
re
la
ti
o
n
sh
ip
b
et
w
ee
n
ed
u
ca
ti
o
n
a
n
d
tr
a
n
sf
er
,
an
d
ed
u
ca
ti
o
n
a
n
d
ﬁ
ve
-y
ea
r
su
rv
iv
al
,
a
t
co
u
n
ty
le
ve
ls
S
ø
r-
T
rø
n
d
el
a
g
(C
en
tr
a
l)
T
ro
m
s
(N
o
rt
h
er
n
)
H
o
rd
a
la
n
d
(W
es
t)
P
re
P
o
st
P
re
P
o
st
P
re
P
o
st
1
9
8
0
-8
6
1
9
8
7
-2
0
0
0
1
9
8
0
-8
4
1
9
8
5
-2
0
0
0
1
9
8
0
-8
6
1
9
8
7
-2
0
0
0
(1
)
(2
)
(3
)
(4
)
(5
)
(6
)
T
r
a
n
s
f
e
r
H
ig
h
er
ed
u
ca
ti
o
n
0
.0
5
7
0
.0
0
8
0
.0
3
6
0
.0
1
5
0
.0
2
4
0
.0
1
8
(0
.0
1
3
)*
*
*
(0
.0
0
4
)*
*
(0
.0
5
2
)
(0
.0
0
8
)*
(0
.0
0
6
)*
*
*
(0
.0
0
7
)*
*
*
S
u
r
v
i
v
a
l
H
ig
h
er
ed
u
ca
ti
o
n
0
.0
7
7
0
.0
3
8
0
.0
3
8
0
.0
2
3
0
.0
2
6
0
.0
4
0
(0
.0
0
8
)*
*
*
(0
.0
0
7
)*
*
*
(0
.0
3
0
)
(0
.0
1
7
)
(0
.0
1
6
)
(0
.0
1
1
)*
*
*
C
o
n
tr
o
ll
in
g
fo
r
d
is
ea
se
ch
a
r
Y
es
Y
es
Y
es
Y
es
Y
es
Y
es
N
o
o
f
o
b
s
4
2
6
9
9
4
6
2
1
5
6
3
5
5
9
4
6
4
8
1
1
5
,2
9
3
S
ee
T
a
b
le
1
.
17
diﬀerences in treatment, this means that the diﬀerence in survival before the
reform corresponded to nine years of progress in cancer treatment (assuming
that all changes in cancer survival rates are due to better treatment).
In the Northern health region, the diﬀerences in both survival and transfer
probabilities for patients with a higher education (relative to patients with a
lower education) was highest in the post-reform period (columns (5) and (6)).
The point estimates for the pre-reform period are not statistically signiﬁcant,
however. In the Western health region, which had a regional cancer ward dur-
ing the entire period under consideration, the diﬀerence in transfer probability
between education groups was also highest in the period 1980-1986. However,
the reverse was true for the diﬀerence in survival probabilities, which indicates
a general compression of inequalities in cancer survival over time in Norway.
Table 2 reports results based on the sample of patients residing in the
counties where the university hospitals are located (Troms, Sør-Trøndelag and
Hordaland). The results do not change much for the Central and Western health
regions when the counties furthest from the university hospitals are excluded.
For the Northern health region, on the other hand, the estimated eﬀect of edu-
cation becomes considerably smaller in the post-reform period for both transfer
and survival compared to the baseline analysis.
In summary, after the opening of regional cancer wards, the proportion of
cancer patients receiving treatment at the national hospitals in Oslo fell dramat-
ically. Moreover, the fall in the transfer rate was relatively steeper for patients
with higher education than for patients with lower education (especially when
focusing on the county in which the regional cancer ward is located). At the
same time, we also saw a decline in the diﬀerence in the survival probability be-
tween patients with higher and lower education. Taken together, these ﬁndings
indicate that the newly opened regional cancer wards may have been of lower
quality than the wards at the well-established hospitals in Oslo, and that access
to or utilization of specialized treatment may be part of the explanation of why
patients with higher education survive cancer to a greater extent than patients
with a lower education. We explore this in more detail in the next section.
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4 The eﬀect of specialized treatment on overall
cancer survival
The opening of regional cancer wards at the teaching hospitals in Tromsø
(Northern region) and Trondheim (Central region) in the 1980's led to sudden
and large drops in transfer probability from the Northern and Central health
regions. At the same time, the transfer probability in the Western health re-
gion remained almost unchanged (recall Figure 2). This motivates the following
diﬀerence-in-diﬀerence (DiD) speciﬁcation:
surijt+5 = CN it + postjt + ψ(CN it ∗ postjt) +Xiν + θj + dt + uijt (1)
surijt+5 is a dummy variable that equals one if patient i in county j was still
alive ﬁve years after being diagnosed with cancer, CNit is a dummy variable
taking the value one if the patient was resident in the Central or Northern
health region at the time of diagnosis (the 'treatment group') and zero if the
patient was resident in the Western health region (the 'control group'), while,
postjt is a dummy variable taking the value one if diagnosis year ≥ the year
of the opening of the regional cancer ward (1985 for the Northern and 1987
for the Central region), and zero otherwise. Our parameter of interest is the
diﬀerences-in-diﬀerences parameter ψ. As discussed above, the care provided
at newly opened cancer wards may have been of lower quality than the care
provided at the well-established national hospitals, especially during the period
shortly after they were established. If this is the case, we should expect that
ψ < 0. To take account of such temporary start-up eﬀects, we allow for diﬀerent
eﬀects in the short and long run and provide separate results for the ﬁrst ﬁve
years after the opening of a regional cancer ward (post1jt) and the succeeding
period (post2jt).
22 Furthermore, Xi is a vector of observed characteristics of
the patient (such as type of cancer (ICD10), stage, age at diagnosis, gender
and education), whereas θj and dt are county and year of diagnosis dummies.
Finally, uijt is an error term.
Table 3 reports the results from estimating Eq.(1). It shows that the relative
prospects for surviving cancer deteriorated substantially for patients when new
wards were established in their region. When regional cancer wards were estab-
22Post1 = 1987-1991 for the Central region and 1985-1989 for the Northern region. Post2
= 1992-2000 for the Central region and 1990-2000 for the Northern region.
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lished in the Central and Northern regions, the survival probability declined by
1.6 percentage points for patients residing in those regions compared to those
living in the Western region. The eﬀect is statistically signiﬁcant at the one
percent level (see column (1)). The eﬀect does not seem to be transitory, i.e.,
it is present both in the ﬁrst ﬁve years after the opening (post1) and thereafter
(post2) (see column 2). As already discussed, the establishment of regional
cancer wards may have been of particular relevance to those residing close to
the university hospitals (due to long travel distances, especially in the North).
In order to take this into account, we also conducted separate analyses for the
counties where the university hospitals are located (Troms, Sør-Trøndelag and
Hordaland). The results, which are presented in columns (3) and (4), show that
the point estimates increase slightly relative to column (2). Even though the
sample is reduced by 60%, the eﬀect is statistically signiﬁcant for both post-
reform periods at the ﬁve percent level. A relative decline in cancer survival of
more than two percentage points is substantial, when we take into account that
the overall survival probability was around 50%. It strongly suggests that the
treatment received by patients from the counties of Sør-Trøndelag and Troms
deteriorated relative to national best practice standards after the establishment
of the new wards.
In a diﬀerences-in-diﬀerences research design, it is always a concern that the
parameter estimate of interest may be biased by diﬀerential time trends. In
our case, if characteristics not controlled for in our analysis, but still aﬀecting
cancer survival, changed over time but diﬀerently in the regions studied, this
could have aﬀect our results. Such changes would typically be gradual. To
check the robustness of our results in this respect, we estimate year-speciﬁc
DiD estimates, which are shown in 7. It is evident that the survival rate in the
Northern health region started to deviate the year after the regional cancer ward
opened. This eﬀect is also visible in the raw data (recall Figure 3).The pattern
is less clear for the Central Region, although point estimates are also negative
here for the period 1989-91 compared to the period before the establishment
of a regional cancer ward. Importantly, there is no trace of any 'reform' eﬀect
prior to the actual reform. The results are reported in more detail in Appendix
Table 8.
Another concern is that the opening of regional cancer wards also changed
the composition of the cancer patients, which could potentially bias our results.
Figures 4 and 5, which document an equal trend in both cancer incidences and
stage at diagnosis in the Western, Central and Northern health regions, suggest
20
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Figure 7: Year speciﬁc DiD estimates, survival probabilities
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Note: The ﬁrst vertical lines indicate the opening of the regional cancer wards.
The second vertical lines indicate when transfer rates were at the same level as
in the Western Health Region.
that such compositional eﬀects are not driving our results, however.
According to national guidelines, certain rare cancer forms would continue
to be treated at highly specialized hospitals in the Oslo region, also after the
opening of the regional cancer wards (see Appendix Table 6). Examples of such
cancer forms include most bone cancer forms, many of the head-and-neck cancer
forms, many of the CNS tumors, and most soft-tissue sarcomas. As a robustness
check, we limit our analysis to only include the four most common cancer types
in our cohort (colorectal, lung, breast, and prostate cancer). Appendix Table 9
shows the results based on the inclusion of these four cancer types only. The
results are basically similar to those reported in Table 3.
Overall, the results consistently show that the establishment of regional can-
cer wards had a negative eﬀect on cancer survival. The results are thus infor-
mative about the quality of care provided by the highly specialized national
hospitals located in Oslo.
5 The eﬀect of specialized treatment on educa-
tional inequalities
As already documented in Tables 1 and 2, the diﬀerence in both transfer and
survival probability between patients with higher and lower education appears
to have decreased after the opening of the regional cancer wards. To investigate
this pattern in more detail, we estimate the following diﬀerences-in-diﬀerences-
in-diﬀerences (DiDiD) speciﬁcation:
22
surijt+5 = CNit+postjt+θEdi+ψ(CNit ∗postjt)+µ(Edi ∗postjt ∗CNit) (2)
+ρ(Edi ∗ postjt) + pi(CNit ∗ Edi) +Xiν + θ∗j + d∗t + u∗ijt
As in equation (1), the diﬀerences-in-diﬀerences parameter ψ measures the
average eﬀect of regional cancer treatment on survival. The interaction terms
between higher education, Edi, the region dummy CNi and the decentralization
dummy postjt are new in equation (2) compared to equation (1).
The new parameter of interest is the diﬀerences-in-diﬀerences-in-diﬀerences
parameter µ. A negative µ implies that educational inequalities in survival
probabilities fell after the opening of regional cancer wards. The total eﬀect of
restricting access to treatment in Oslo for a patient with a higher education is
ψ + µ, while it is ψfor a patient with a low education.
The DiDiD estimates are presented in Table 4. The results clearly indicate
that it was the highly educated who suﬀered most strongly as a result of the
reform. All speciﬁcations indicate a decrease in the diﬀerences in survival rates
of about four percentage points, e.g., in column (1), where the decline for those
with lower education was 1.3 percentage points, whereas it was 5.6 percentage
points for the highly educated. The eﬀect is statistically signiﬁcant at the ﬁve
percent level when conducting the analysis at health region level (column (1)).
When we split the post-reform period into two, we ﬁnd statistically signiﬁcant
eﬀects of a similar magnitude for both periods. At the county level, the point
estimates are statistically insigniﬁcant, but of a similar magnitude as in the
baseline analysis.23
As in the analysis in the previous section, diﬀerent time trends in the ed-
ucational composition of the treatment and control groups may give grounds
for concern. In Appendix Figure 10, we report the trend in the proportion of
the whole population (between 16 and 75 years) with a higher education sep-
arately for the diﬀerent regions.24 As the trend is very similar across regions,
compositional eﬀects in education are unlikely to drive our results.
Previous research has shown that individuals with a lower education also
23Appendix Table 10 shows the results from including only the four most common cancer
types. The results are basically similar to those reported in Table 4.
24The ﬁgure is constructed using separate data collected at the regional level from the
Norwegian Social Science Data Service (NSD).
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tend to suﬀer from other serious diseases and therefore receive diﬀerent types
of treatment for such co-morbidities (Aarts et al, 2012). This may further
necessitate modiﬁcations in the cancer treatment protocol. Unfortunately, we
do not have information about such co-morbidities. However, given that the
trend in such co-morbidities is likely to be the same in the treatment and control
regions, this should not be a source of bias in our research design.
All in all, a very clear pattern emerges from the results reported in this
section. Diﬀerences in survival rates with respect to education fell substantially
after the opening of the new regional cancer wards. As we documented earlier,
this went hand in hand with a decline in transfer probability, which was greatest
for the highly educated. The results strongly suggest that the relative fall in
survival probability for the highly educated was the result of a reduction in
the advantage they had as regards access to highly specialized treatment at the
national hospitals.
6 Conclusion
The point of departure for this paper is the well-known fact that highly educated
individuals survive cancer to a greater extent than others. We test the hypothe-
sis that this may in part be driven by highly educated individuals having better
access to, or to a greater extent utilizing, specialized cancer treatment. In a
welfare state with strong egalitarian preferences and a publicly ﬁnanced health
care system, diﬀerential use of selected treatment options could be seen as an
indication that the system is functioning sub-optimally.
We document that, among cancer patients residing outside the Oslo region,
highly educated patients, and doctors in particular, are more likely than other
patients to be transferred to the two specialized hospitals in the capital. Since
these hospitals are likely to oﬀer more advanced treatment provided by a highly
skilled staﬀ, such transfers would also be expected to increase survival proba-
bilites. This is hard to investigate empirically, since patients who suﬀer from the
most severe diseases are the ones that are most likely to be transferred. However,
we ﬁnd that the educational inequalities in transfer become more pronounced
when we condition on a rich set of disease characteristics. It is also striking that
patients who have a medical education are the ones with the highest transfer
and survival probabilities conditional on disease characteristics. It is possible, of
course, that unobserved patient and disease characteristics vary systematically
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diﬀerently across types and levels of education compared to the observed char-
acteristics, but we ﬁnd this unlikely. While these ﬁndings in themselves suggest
that educated patients utilize specialized treatment to a greater extent, they do
not establish that this explains (part of) the educational inequality in survival.
To do this, we need an exogenous source of variation in access to specialized
treatment. The approach we used to investigate this empirically was to utilize
a reform in cancer treatment in Norway in the 1980's, when specialized can-
cer wards were established in the Central and Northern health regions. As a
consequence of this, the proportion of patients transferred to the national spe-
cialized hospitals fell dramatically because of increased regional capacity and
more explicit transfer regulations. We ﬁnd that the reform had a negative eﬀect
on survival probability for patients residing in the regions where the new wards
were established (i.e., survival improved less than in other regions). This was
particularly true for highly educated patients. These results indicate that the
initial quality of treatment or care at the new regional wards may have been
lower than that oﬀered at the national hospitals, but also that the reform re-
duced the educational inequalities in cancer survival. Taken at face value, the
point estimates suggest that a substantial part of the educational diﬀerence in
cancer survival in these regions was due to diﬀerences in access to and utilization
of specialized treatment.
It is not surprising that a fully privatized health care system can produce
social inequalities. Our results suggest that, even in a public health care system,
socioeconomic inequalities in cancer survival can arise when health personnel
have substantial discretion as regards referral practices. They also highlight
that the organization of health care may involve a painful trade-oﬀ between
proximity and quality of treatment.
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Table 5: Summary statistics of the variables used in the analyses
Mean St.dev Min Max
Survival ﬁve years after diagnosis 0.502 0.500 0 1
Transfer to the Oslo region 0.115 0.320 0 1
Age at diagnosis 61.4 11.03 30 75
Year of diagnosis 1991 6.07 1980 2000
University level education (15 years or more) 0.101 0.301 0 1
Gender dummy (1=Female, 0=Male) 0.470 0.500 0 1
Stage at diagnosis
Localized 0.437 0.500 0 1
Regional spread 0.171 0.377 0 1
Distant spread 0.195 0.396 0 1
Unknown spread 0.197 0.398 0 1
Cancer type (encoded by icd-10)
Head and neck, incl eye (C00-14, C30-32, C69) 0.034 0.180 0 1
Esophageal (C15) 0.007 0.081 0 1
Stomach (C16) 0.045 0.207 0 1
Small intestine (C17) 0.004 0.059 0 1
Colorectal (C18-C21) 0.141 0.348 0 1
Hepatic/biliary (C22-C24) 0.010 0.101 0 1
Pancreatic (C25) 0.030 0.171 0 1
Lung (C34, C39) 0.099 0.299 0 1
Endocrine (C37, C73-75) 0.019 0.136 0 1
Bone (C40-C41) 0.002 0.041 0 1
Skin (C43-44) 0.067 0.250 0 1
Soft tissue (C45-49) 0.004 0.061 0 1
Peritoneal (C48) 0.002 0.041 0 1
Breast (C50) 0.122 0.327 0 1
Cervical/uterine (C53-55) 0.049 0.216 0 1
Ovarian (C56) 0.028 0.166 0 1
Other female gyn. (C51-52, C57-58) 0.004 0.063 0 1
Prostate (C61) 0.107 0.309 0 1
Testicular (C62) 0.011 0.103 0 1
Penile/other male genital (C60, C63) 0.002 0.040 0 1
Renal/bladder (C64-68) 0.082 0.274 0 1
CNS tumor (C69-72, D32-33) 0.035 0.183 0 1
Leukemia/lymphoma (C81-85, C90-95) 0.070 0.255 0 1
Other or unspeciﬁed (C26, C38, C76-80, C86-88, C96-97) 0.028 0.166 0 1
No of observations = 99,988.
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Table 6: Transfer proportions before and after the opening of regional cancer
hospitals
Central North
ICD10 0 1 0 1
Head and neck 0.688 0.234 0.724 0.364
Esophageal 0.356 0.062 0.568 0.057
Stomach 0.037 0.022 0.034 0.027
Small intestine 0.125 0.147 0.182 0.143
Colorectal 0.103 0.037 0.137 0.057
Hepatic/biliary 0.127 0.068 0.127 0.080
Pancreatic 0.042 0.018 0.069 0.024
Lung 0.466 0.044 0.584 0.080
Endocrine 0.337 0.096 0.490 0.186
Bone 0.667 0.417 0.667 0.692
Skin 0.122 0.031 0.228 0.066
Soft tissue 0.520 0.169 0.828 0.417
Peritoneal 0.462 0.167 0.200 0.250
Breast 0.232 0.039 0.358 0.087
Cervical/uterine 0.912 0.183 0.919 0.296
Ovarian 0.718 0.191 0.819 0.265
Other female gyn. 0.780 0.170 0.714 0.287
Prostate 0.062 0.013 0.133 0.033
Testicular 0.776 0.069 0.884 0.167
Penile/other male genital 0.467 0.062 0.429 0.118
Renal/bladder 0.234 0.037 0.267 0.062
CNS tumor 0.458 0.089 0.747 0.183
Leukemia/lymphoma 0.264 0.054 0.293 0.091
Other or unspeciﬁed 0.170 0.033 0.231 0.079
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Table 8: The eﬀect of transfer on survival ﬁve years after diagnosis, year-speciﬁc
DiD estimates
(1) (2)
Treatment -0.005 (0.017) 0.015 (0.016)
Treatment*Year
(1980=ref)
1981 -0.022 (0.022) -0.007 (0.021)
1982 0.016 (0.022) 0.010 (0.020)
1983 0.011 (0.022) 0.020 (0.021)
1984 0.012 (0.022) 0.011 (0.020)
1985 -0.005 (0.022) -0.004 (0.020)
1986 -0.021 (0.022) -0.009 (0.020)
1987 -0.037 (0.022)* 0.001 (0.021)
1988 -0.041 (0.022)* 0.002 (0.020)
1989 -0.050 (0.022)** -0.027 (0.020)
1990 -0.055 (0.022)** -0.018 (0.020)
1991 -0.011 (0.022) -0.022 (0.020)
1992 -0.029 (0.022) -0.008 (0.020)
1993 -0.023 (0.022) 0.024 (0.020)
1994 -0.027 (0.022) -0.012 (0.020)
1995 -0.032 (0.021) 0.009 (0.020)
1996 -0.029 (0.021) -0.003 (0.019)
1997 -0.048 (0.021)** -0.010 (0.019)
1998 -0.067 (0.021)** -0.012 (0.019)
1999 -0.047 (0.021)** -0.012 (0.019)
2000 -0.024 (0.020) -0.011 (0.019)
Dep var (mean) 0.110 0.102
Treatment North Central
Control West West
R-square 0.3626
No of obs 67,503 76,913
Note: The dependent variable is a dummy variable that equals one if the pa-
tient is alive ﬁve years after diagnosis. Standard errors within brackets are het-
eroscedastic robust. Included in all speciﬁcations are a constant term, dummy
variables for educational level, gender, age at diagnosis, disease characteristics,
year of diagnosis and county of residence. */**/*** denote statistical signiﬁ-
cance at the 10/5/1 percent levels, respectively.
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